Literature DB >> 15822331

The systematic evaluation of the chest radiograph in cystic fibrosis.

A R Chrispin, A P Norman.   

Abstract

Entities:  

Mesh:

Year:  1974        PMID: 15822331     DOI: 10.1007/bf01314939

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


× No keyword cloud information.
  7 in total

1.  Pulmonary changes in cystic fibrosis of the pancreas. A radio-pathological study.

Authors:  C J HODSON; N E FRANCE
Journal:  Clin Radiol       Date:  1962-01       Impact factor: 2.350

2.  Distribution of blood flow and ventilation-perfusion ratio in the lung, measured with radioactive carbon dioxide.

Authors:  J B WEST; C T DOLLERY
Journal:  J Appl Physiol       Date:  1960-05       Impact factor: 3.531

3.  Fibrocystic disease of the pancreas: roentgen manifestations.

Authors:  H WHITE
Journal:  Radiology       Date:  1958-12       Impact factor: 11.105

4.  Lobar ventilation and oxygen uptake in man; influence of body position.

Authors:  S B MATTSON; E CARLENS
Journal:  J Thorac Surg       Date:  1955-12

5.  Roentgen changes associated with pancreatic insufficiency in early life.

Authors:  E B D NEUHAUSER
Journal:  Radiology       Date:  1946-04       Impact factor: 11.105

6.  The correlation of radiological changes with pulmonary function in cystic fibrosis.

Authors:  B J Reilly; E A Featherby; T R Weng; D N Crozier; A Duic; H Levison
Journal:  Radiology       Date:  1971-02       Impact factor: 11.105

7.  Life-table for cystic fibrosis.

Authors:  D J Mantle; A P Norman
Journal:  Br Med J       Date:  1966-11-19
  7 in total
  101 in total

1.  Airway and interstitial lung disease are distinct entities in paediatric common variable immunodeficiency.

Authors:  A A J M van de Ven; P A de Jong; D P Hoytema van Konijnenburg; O A M Kessels; M Boes; E A M Sanders; S W J Terheggen-Lagro; J M van Montfrans
Journal:  Clin Exp Immunol       Date:  2011-06-02       Impact factor: 4.330

Review 2.  Pathogenesis and management of lung disease in cystic fibrosis.

Authors:  M S Zach
Journal:  J R Soc Med       Date:  1991       Impact factor: 5.344

3.  Serum IgA antibodies against Pseudomonas aeruginosa in cystic fibrosis.

Authors:  M M Brett; A T Ghoneim; J M Littlewood
Journal:  Arch Dis Child       Date:  1990-03       Impact factor: 3.791

4.  [Specific characteristics of chest X‑ray in childhood : Basics for radiologists].

Authors:  K Schneider
Journal:  Radiologe       Date:  2018-04       Impact factor: 0.635

5.  Treatment of pseudomonas aeruginosa colonisation in cystic fibrosis.

Authors:  G Steinkamp; B Tümmler; R Malottke; H von der Hardt
Journal:  Arch Dis Child       Date:  1989-07       Impact factor: 3.791

6.  Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin.

Authors:  U B Schaad; J Wedgwood-Krucko; K Guenin; U Buehlmann; R Kraemer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

7.  A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis.

Authors:  I M Bowler; S P Wolfe; H M Owens; T A Sheldon; J M Littlewood; M P Walters
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

8.  Search for mutations in pancreatic sufficient cystic fibrosis Italian patients: detection of 90% of molecular defects and identification of three novel mutations.

Authors:  V Brancolini; L Cremonesi; E Belloni; E Pappalardo; R Bordoni; M Seia; S Russo; R Padoan; A Giunta; M Ferrari
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

9.  Chest physiotherapy in cystic fibrosis: a comparative study of autogenic drainage and the active cycle of breathing techniques with postural drainage.

Authors:  S Miller; D O Hall; C B Clayton; R Nelson
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

10.  Cystic fibrosis and allergic bronchopulmonary aspergillosis.

Authors:  E J Simmonds; J M Littlewood; E G Evans
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.